{"id":"W4378650540","doi":"10.1016/j.eururo.2023.05.011","title":"Checkpoint Inhibitors in Urothelial Carcinoma—Future Directions and Biomarker Selection","year":2023,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; U.S. Department of Veterans Affairs","keywords":"Medicine; Metastatic Urothelial Carcinoma; Nivolumab; Cystectomy; Oncology; Internal medicine; Pembrolizumab; Bladder cancer; Clinical endpoint; Clinical trial; Cancer; Immunotherapy; Urothelial carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001295949,0.0008491424,0.002344271,0.001529671,0.0001867126,0.001484008,0.001002414,0.001078909,0.00391437],"category_scores_gemma":[0.001544974,0.0003296121,0.001114177,0.001757934,0.0004033708,0.001251061,0.0007396491,0.002323865,0.00101363],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006994705,"about_ca_system_score_gemma":0.001501382,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001288239,"about_ca_topic_score_gemma":0.003940603,"domain_scores_codex":[0.9997411,0.00006444467,0.00004821218,0.00004794555,0.00006766282,0.00003053094],"domain_scores_gemma":[0.9993536,0.0003617291,0.0001204694,0.00001236036,0.0001145008,0.00003741158],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002787679,0.00007090846,0.0003578963,0.02340712,0.0003731926,0.00009008651,0.00003081173,0.0006070859,0.0006229631,0.001911799,0.01885553,0.9533937],"study_design_scores_gemma":[0.0003651047,0.0006893216,0.003309858,0.02696592,0.002106502,0.001183954,0.0001239013,0.0007319074,0.0006044052,0.004684241,0.9591734,0.00006138503],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006817559,0.9993584,0.00004370105,0.0002312462,0.00007888937,0.000002989365,0.0000172992,0.000003703168,0.000195662],"genre_scores_gemma":[0.0007732803,0.9984843,0.0001299749,0.0003099563,0.0001064422,0.000006094371,0.00003222155,8.850795e-7,0.0001569605],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00391437,"threshold_uncertainty_score":0.01309484,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04715193843860762,"score_gpt":0.3220179099081214,"score_spread":0.2748659714695138,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}